Connexin-made channels as pharmacological targets

Current Pharmaceutical Design

Volumn 11, Issue 15, 2005, Pages 1941-1958

  Hervé, Jean Claude ^a   Sarrouilhe, D ^b  

^a UMR CNRS 6187   (France)

^b UNIVERSITÉ DE POITIERS   (France)

Author keywords

Connexin; Gap junctions; Junctional uncoupling

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; 2,4 DINITROPHENOL; 5 NITRO 2 (3 PHENYLPROPYLAMINO)BENZOIC ACID; ALENDRONIC ACID; ANANDAMIDE; ANGIOTENSIN; ANTIARRHYTHMIC PEPTIDE; ANTIARRHYTHMIC PEPTIDE 10; ANTIMYCIN A1; ARACHIDONIC ACID; BREFELDIN A; CHLORIDE CHANNEL BLOCKING AGENT; CHORIONIC GONADOTROPIN; CLOMIFENE; DIACETYL OXIME; ENALAPRIL; ESTRADIOL; FLUFENAMIC ACID; FOLLITROPIN; GADOLINIUM; GAP JUNCTION PROTEIN; GENTAMICIN; GLYCYRRHETINIC ACID; GOSSYPOL; GROWTH FACTOR; HALOTHANE; HEPTANOL; INSULIN; INTERLEUKIN 1BETA; LOSARTAN; MECLOFENAMIC ACID; MONENSIN; NATRIURETIC FACTOR; NIFLUMIC ACID; OLEAMIDE; OUABAIN; PENTACHLOROPHENOL; PHENOL; POLYPHENOL; QUININE DERIVATIVE; RESVERATROL; ROTIGAPTIDE; TAMOXIFEN; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

BREAST CANCER; CARDIOVASCULAR DISEASE; CATARACT; CELL ACTIVITY; CELL COMMUNICATION; CELL SYNCHRONIZATION; DRUG BLOOD LEVEL; DRUG INDICATION; DRUG MECHANISM; DRUG STRUCTURE; DRUG TARGETING; DYSMENORRHEA; ELECTROLYTE TRANSPORT; GAP JUNCTION; GENE MUTATION; HEARING IMPAIRMENT; HEART CONTRACTION; HEART PROTECTION; HORMONE ACTION; HUMAN; HUMAN GENOME; INSULIN RELEASE; MENORRHAGIA; NERVE CELL EXCITABILITY; NERVE CELL PLASTICITY; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; OSTEOARTHRITIS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SKIN DISEASE; SMOOTH MUSCLE CONTRACTION; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; ANTI-INFECTIVE AGENTS; BREFELDIN A; CONNEXINS; GAP JUNCTIONS; HUMANS; ION CHANNELS; MOLECULAR SEQUENCE DATA; MONENSIN;

EID: 20044369560     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612054021060     Document Type: Review

References (216)

1. Harris AL. Emerging issues of connexin channels: biophysics fills the gap. Q Rev Biophys 2001; 34: 325-472.
2. Evans WH, Martin PE. Gap junctions: structure and function. Mol Membr Biol 2002; 19: 121-36.
3. Saez JC, Berthoud VM, Branes MC, Martinez AD, Beyer EC. Plasma membrane channels formed by connexins: their regulation and functions. Physiol Rev 2003; 83: 1359-400.
4. Peracchia C, Lazrak A, Peracchia LL. Molecular models of channel interaction and gating in gap junctions. In: Peracchia C Ed, Handbook of membrane channels: molecular and cellular physiology, San Diego USA, Academic Press 1995; 361-77.
5. Sohl G, Willecke K. Gap junctions and the connexin protein family. Cardiovasc Res 2004; 62: 228-32.
6. Lin JH, Weigel H, Cotrina ML, Liu S, Bueno E, Hansen AJ, et al. Gap-junction-mediated propagation and amplification of cell injury. Nat Neurosci 1998; 1: 494-500.
7. Garcia-Dorado D, Rodriguez-Sinovas A, Ruiz-Meana M. Gap junction-mediated spread of cell injury and death during myocardial ischaemia-reperfusion. Cardiovasc Res 2004; 61: 386-401.
8. Edwards GO, Botchway SW, Hirst G, Wharton CW, Chipman JK, Meldrum RA. Gap junction communication dynamics and bystander effects from ultrasoft X-rays. Br J Cancer 2004; 90: 1450-6.
9. Gareri P, Condorelli D, Belluardo N, Gratteri S, Ferreri G, Donato Di Paola E, et al. Influence of carbenoxolone on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice. Eur J Pharmacol 2004; 484: 49-56.
10. Wilders R, Wagner MB, Golod DA, Kumar R, Wang YG, Goolsby WN, et al. Effects of anisotropy on the development of cardiac arrhythmias associated with focal activity. Pflügers Arch 2000; 441: 301-12.
11. Tanaka T, Yamasaki H, Mesnil M. Induction of a bystander effect in HeLa cells by using a bigenic vector carrying viral thymidine kinase and connexin32 genes. Mol Carcinog 2001; 30: 176-80.
12. Nakase T, Naus CC. Gap junctions and neurological disorders of the central nervous system. Biochim Biophys Acta 2004; 1662: 149-58.
13. Parpura V, Scemes E, Spray DC. Mechanisms of glutamate release from astrocytes: gap junction "hemichannels", purinergic receptors and exocytotic release. Neurochem Int 2004; 45: 259-64.
14. Neyton J, Trautmann A. Single-channel currents of an intercellular junction. Nature 1985; 317: 331-5.
15. Veenstra RD, DeHaan RL. Measurement of single channel currents from cardiac gap junctions. Science 1986; 233: 972-4.
16. Takens-Kwak BR, Jongsma HJ, Rook MB, Van Ginneken AC. Mechanism of heptanol-induced uncoupling of cardiac gap junctions: a perforated patch-clamp study. Am J Physiol 1992; 262: C1531-8.
17. Verrecchia F, Duthe F, Duval S, Duchatelle I, Sarrouilhe D, Hervé JC. ATP counteracts the rundown of gap junctional channels of rat ventricular myocytes by promoting protein phosphorylation. J Physiol (Lond) 1999; 516: 447-59.
18. Kanno Y, Loewenstein WR. Intercellular diffusion. Science 1964; 143: 959-60.
19. el-Fouly MH, Trosko JE, Chang CC. Scrape-loading and dye transfer. A rapid and simple technique to study gap junctional intercellular communication. Exp Cell Res 1987; 168: 422-30.
20. Pepper MS, Spray DC, Chanson M, Montesano R, Orci L, Meda P. Junctional communication is induced in migrating capillary endothelial cells. J Cell Biol 1989; 109: 3027-38.
21. Wade MH, Trosko JE, Schindler M. A fluorescence photobleaching assay of gap junction-mediated communication between human cells. Science 1986; 232: 525-8.
22. Rozental R, Srinivas M, Spray DC. How to close a gap junction channel. Efficacies and potencies of uncoupling agents. Methods Mol Biol 2001; 154: 447-76.
23. Délèze J, Delage B, Hentati-Ksibi O, Verrecchia F, Hervé JC. Fluorescence recovery after photobleaching. Methods Mol Biol 2001; 154: 313-27.
24. Perez-Armendariz M, Roy C, Spray DC, Bennett MV. Biophysical properties of gap junctions between freshly dispersed pairs of mouse pancreatic beta cells. Biophys J 1991; 59: 76-92.
25. Bedner P, Niessen H, Odermatt B, Willecke K, Harz H. A method to determine the relative cAMP permeability of connexin channels. Exp Cell Res 2003; 291: 25-35.
26. Johnston MF, Simon SA, Ramon F. Interaction of anaesthetics with electrical synapses. Nature 1980; 286: 498-500.
27. Délèze J, Hervé JC. Effect of several uncouplers of cell-to-cell communication on gap junction morphology in mammalian heart. J Membr Biol 1983; 74: 203-15.
28. Bernardini G, Peracchia C, Peracchia LL. Reversible effects of heptanol on gap junction structure and cell-to-cell electrical coupling. Eur J Cell Biol 1984; 34: 307-12.
29. Meda P, Bruzzone R, Knodel S, Orci L. Blockage of cell-to-cell communication within pancreatic acini is associated with increased basal release of amylase. J Cell Biol 1986; 103: 475-83.
30. Bastide B, Hervé JC, Cronier L, Délèze J. Rapid onset and calcium independence of the gap junction uncoupling induced by heptanol in cultured heart cells. Pflügers Arch 1995; 429: 386-93.
31. Burt JM, Spray DC. Single-channel events and gating behavior of the cardiac gap junction channel. Proc Natl Acad Sci USA 1988; 85: 3431-4.
32. Eskandari S, Zampighi GA, Leung DW, Wright EM, Loo DD. Inhibition of gap junction hemichannels by chloride channel blockers. J Membr Biol 2002; 185: 93-102.
33. Giaume C, Randriamampita C, Trautmann A. Arachidonic acid closes gap junction channels in rat lacrimal glands. Pflügers Arch 1989; 413: 273-9.
34. Burt JM. Uncoupling of cardiac cells by doxyl stearic acids specificity and mechanism of action. Am J Physiol 1989; 256: C913-24.
35. Burt JM, Massey KD, Minnich BN. Uncoupling of cardiac cells by fatty acids: structure-activity relationships. Am J Physiol 1991; 260: C439-48.
36. Ashton AW, Yokota R, John G, Zhao S, Suadicani SO, Spray DC, et al. Inhibition of endothelial cell migration, intercellular communication, and vascular tube formation by thromboxane A(2). J Biol Chem 1999; 274: 35562-70.
37. Popp R, Brandes RP, Ott G, Busse R, Fleming I. Dynamic modulation of interendothelial gap junctional communication by 11,12-epoxyeicosatrienoic acid. Circ Res 2002; 90: 800-6.
38. Guan X, Cravatt BF, Ehring GR, Hall JE, Boger DL, Lerner RA, et al. The sleep-inducing lipid oleamide deconvolutes gap junction communication and calcium wave transmission in glial cells. J Cell Biol 1997; 139: 1785-92.
39. Venance L, Piomelli D, Glowinski J, Giaume C. Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes. Nature 1995; 376: 590-4.
40. Burt JM, Spray DC. Volatile anesthetics block intercellular communication between neonatal rat myocardial cells. Circ Res 1989; 65: 829-37.
41. He DS, Burt JM. Mechanism and selectivity of the effects of halothane on gap junction channel function. Circ Res 2000; 86: E104-9.
42. Verrecchia F, Kwak BR, Hervé JC. 17β-estradiol-induced blockade of cell-to-cell communication in neonatal rat cardiomyocytes is not mediated by activation of tyrosine kinase, protein kinases A or C. In: Werner E Ed, Gap junctions. Amsterdam NL, IOS Press 1998; 220-4.
43. Tabei T, Ochiai K, Terashima Y, Takanashi N. Serum levels of inhibin in maternal and umbilical blood during pregnancy. Am J Obstet Gynecol 1991; 164: 896-900.
44. Khan-Dawood FS, Dawood MY. Estrogen and progesterone receptor and hormone levels in human myometrium and placenta in term pregnancy. Am J Obstet Gynecol 1984; 150: 501-5.
45. Hervé JC, Pluciennik F, Verrecchia F, Bastide B, Delage B, Joffre M, et al. Influence of the molecular structure of steroids on their ability to interrupt gap junctional communication. J Membr Biol 1996; 149: 179-87.
46. Falkenstein E, Tillmann HC, Christ M, Feuring M, Wehling M. Multiple actions of steroid hormones - a focus on rapid, nongenomic effects. Pharmacol Rev 2000; 52: 513-56.
47. Hevers W, Lüddens H. The diversity of GABAA receptors. Pharmacological and electrophysiological properties of GABAA channel subtypes. Mol Neurobiol 1998; 18: 35-86.
48. 2+ signaling, and gene expression in T lymphocytes. J Exp Med 1998; 188: 1593-602.
49. Rupprecht R, Holsboer F. Neuropsychopharmacological properties of neuroactive steroids. Steroids 1999; 64: 83-91.
50. Hervé JC. Non-genomic effects of steroid hormones on membrane channels. Mini Rev Med Chem 2002; 2: 411-17.
51. Davidson JS, Baumgarten IM, Harley EH. Reversible inhibition of intercellular junctional communication by glycyrrhetinic acid. Biochem Biophys Res Commun 1986; 134: 29-36.
52. Davidson JS, Baumgarten IM. Glycyrrhetinic acid derivatives: a novel class of inhibitors of gap-junctional intercellular communication. Structure-activity relationships. J Pharmacol Exp Ther 1988; 246: 1104-7
53. + currents underlying the action of endothelium-derived hyperpolarizing factor in guinea-pig, rat and human blood vessels. J Physiol (Lond) 2001; 531: 359-73.
54. Bohmer C, Kirschner U, Wehner F. 18-beta-Glycyrrhetinic acid (BGA) as an electrical uncoupler for intracellular recordings in confluent monolayer cultures. Pflügers Arch 2001; 442: 688-92.
55. Guan X, Wilson S, Schlender KK, Ruch RJ. Gap-junction disassembly and connexin 43 dephosphorylation induced by 18 beta-glycyrrhetinic acid. Mol Carcinog 1996; 16: 157-64.
56. Goldberg GS, Moreno AP, Bechberger JF, Hearn SS, Shivers RR, MacPhee DJ, et al. Evidence that disruption of connexon particle arrangements in gap junction plaques is associated with inhibition of gap junctional communication by a glycyrrhetinic acid derivative. Exp Cell Res 1996; 222: 48-53.
57. Negishi M, Irie A, Nagata N, Ichikawa A. Specific binding of glycyrrhetinic acid to the rat liver membrane. Biochim Biophys Acta 1991; 1066: 77-82.
58. de Mello WC. Influence of the sodium pump on intercellular communication in heart fibres: effect of intracellular injection of sodium ion on electrical coupling. J Physiol (Lond) 1976; 263: 171-97.
59. Weingart R. The actions of ouabain on intercellular coupling and conduction velocity in mammalian ventricular muscle. J Physiol (Lond) 1977; 264: 341-65.
60. Dahl G, Isenberg G. Decoupling of heart muscle cells: correlation with increased cytoplasmic calcium activity and with changes of nexus ultrastructure. J Membr Biol 1980; 53: 63-75.
61. Jalife J, Sicouri S, Delmar M, Michaels DC. Electrical uncoupling and impulse propagation in isolated sheep Purkinje fibers. Am J Physiol 1989; 257: H179-89.
62. Martin PE, Hill NS, Kristensen B, Errington RJ, Rachael JTM. Ouabain exerts biphasic effects on connexin functionality and expression in vascular smooth muscle cells. Br J Pharmacol 2004; 141: 374-84.
63. Harks EG, de Roos AD, Peters PH, de Haan LH, Brouwer A, Ypey DL, et al. Fenamates: a novel class of reversible gap junction blockers J Pharmacol Exp Ther 2001; 298: 1033-41.
64. Sinkkonen ST, Mansikkamaki S, Moykkynen T, Luddens H, Uusi-Oukari M, Korpi ER. Receptor subtype-dependent positive and negative modulation of GABA(A) receptor function by niflumic acid, a nonsteroidal anti-inflammatory drug. Mol Pharmacol 2003; 64: 753-63.
65. Srinivas M, Spray DC. Closure of gap junction channels by arylaminobenzoates. Mol Pharmacol 2003; 63: 1389-97.
66. Miller CP. SERMs: evolutionary chemistry, revolutionary biology. Curr Pharm Des 2002; 8: 2089-111.
67. Verrecchia F, Hervé J. Reversible inhibition of gap junctional communication by tamoxifen in cultured cardiac myocytes. Pflügers Arch 1997; 434: 113-6.
68. Mandlekar S, Kong AN. Mechanisms of tamoxifen-induced apoptosis. Apoptosis 2001; 6: 469-77.
69. Wiseman H, Cannon M, Arnstein HR, Barlow DJ. The structural mimicry of membrane sterols by tamoxifen: evidence from cholesterol coefficients and molecular-modelling for its action as a membrane anti-oxidant and an anti-cancer agent. Biochim Biophys Acta 1992; 1138: 197-202.
70. + currents by tamoxifen. J Membr Biol 2001; 181: 125-35.
71. Trump DL, Smith DC, Ellis PG, Rogers MP, Schold SC, Winer EP, et al. High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: phase I trial in combination with vinblastine J Natl Cancer Inst 1992; 84: 1811-6.
72. de Mello WC. Effects of 2,4-dinitrophenol on intercellular communication in mammalian cardiac fibers. Pflügers Arch 1979; 380: 267-76.
73. Sai K, Kang KS, Hirose A, Hasegawa R, Trosko JE, Inoue T. Inhibition of apoptosis by pentachlorophenol in v-myc-transfected rat liver epithelial cells: relation to down-regulation of gap junctional intercellular communication. Cancer Lett 2001; 173: 163-74.
74. Hervé JC, Pluciennik F, Bastide B, Cronier L, Verrecchia F, Malassiné A, et al. Contraceptive gossypol blocks cell-to-cell communication in human and rat cells. Eur J Pharmacol 1996; 313: 243-55.
75. Stoner GD, Mukhtar H. Polyphenols as cancer chemopreventive agents. J Cell Biochem Suppl 1995; 22: 169-80.
76. Nielsen M, Ruch RJ, Vang O. Resveratrol reverses tumour-promoter-induced inhibition of gap-junctional intercellular communication. Biochem Biophys Res Commun 2000; 275: 804-9.
77. Chaumontet C, Bex V, Gaillard-Sanchez I, Seillan-Heberden C, Suschetet M, Martel P. Apigenin and tangeretin enhance gap junctional intercellular communication in rat liver epithelial cells. Carcinogenesis 1994; 15: 2325-30.
78. Dinter A, Berger EG. Golgi-disturbing agents. Histochem Cell Biol 1998; 109: 571-90.
79. Laird DW, Castillo M, Kasprzak L. Gap junction turnover, intracellular trafficking, and phosphorylation of connexin43 in brefeldin A-treated rat mammary tumour cells. J Cell Biol 1995; 131: 1193-203.
80. George CH, Kendall JM, Evans WH. Intracellular trafficking pathways in the assembly of connexins into gap junctions. J Biol Chem 1999; 274: 8678-85.
81. Martin PE, Blundell G, Ahmad S, Errington RJ, Evans WH. Multiple pathways in the trafficking and assembly of connexin 26, 32 and 43 into gap junction intercellular communication channels. J Cell Sci 2001; 114: 3845-55.
82. Thomas MA, Zosso N, Scerri I, Demaurex N, Chanson M, Staub O. A tyrosine-based sorting signal is involved in connexin43 stability and gap junction turnover. J Cell Sci 2003; 116: 2213-22.
83. Laing JG, Tadros PN, Westphale EM, Beyer EC. Degradation of connexin43 gap junctions involves both the proteasome and the lysosome. Exp Cell Res 1997; 236: 482-92.
84. Cruciani V, Leithe E, Mikalsen SO. Ilimaquinone inhibits gap-junctional communication prior to Golgi fragmentation and block in protein transport. Exp Cell Res 2003; 287: 130-42.
85. Burghardt RC, Barhoumi R, Sewall TC, Bowen JA. Cyclic AMP induces rapid increases in gap junction permeability and changes in the cellular distribution of connexin43. J Membr Biol 1995; 148: 243-53.
86. Todt I, Ngezahayo A, Ernst A, Kolb HA. Inhibition of gap junctional coupling in cochlear supporting cells by gentamicin. Pflügers Arch 1999; 438: 865-7.
87. Vera B, Sánchez-Abarca LI, Bolaños JP, Medina JP. Inhibition of astrocyte gap junctional communication by ATP depletion is reversed by calcium sequestration. FEBS Lett 1996; 392: 225-228
88. Martinez AD, Saez JC Regulation of astrocyte gap junctions by hypoxia-reoxygenation. Brain Res Rev 2000; 32: 250-8.
89. Duthe F, Plaisance I, Sarrouilhe D, Hervé JC. Endogenous protein phosphatase-1 runs down gap junctional communication of rat ventricular myocytes. Am J Physiol 2001; 281: C1648-56.
90. Plaisance I, Duthe F, Sarrouilhe D, Hervé JC. The metabolic inhibitor antimycin A can disrupt cell-to-cell communication by an ATP- and Ca(2+)-indcpendent mechanism. Pflügers Arch 2003; 447:181-94.
91. Tzung SP, Kim KM, Basanez G, Giedt CD, Simon J, Zimmerberg J, et al. Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3. Nat Cell Biol 2001; 3: 183-91.
92. Maldonado PE, Rose B, Loewenstein WR. Growth factors modulate junctional cell-to-cell communication. J Membr Biol 1988; 106: 203-10.
93. Madhukar BV, Oh SY, Chang CC, Wade M, Trosko JE. Altered regulation of intercellular communication by epidermal growth factor, transforming growth factor-beta and peptide hormones in normal human keratinocytes. Carcinogenesis 1989; 10: 13-20.
94. Oh SY, Schmidt SA, Murray AW. Epidermal growth factor inhibits gap junctional communication and stimulates serine-phosphorylation of connexin43 in WB cells by a protein kinase C-independent mechanism. Cell Adhes Commun 1993; 1: 143-9.
95. Doble BW, Chen Y, Bosc DG, Litchfield DW, Kardami E. Fibroblast growth factor-2 decreases metabolic coupling and stimulates phosphorylation as well as masking of connexin43 epitopes in cardiac myocytes. Circ Res 1996; 79: 647-58.
96. Homma N, Alvarado JL, Coombs W, Stergiopoulos K, Taffet SM, Lau AF, et al. A particle-receptor model for the insulin-induced closure of connexin43 channels. Circ Res 1998; 83: 27-32.
97. Aonuma S, Kohama Y, Akai K, Iwasaki S. Studies on heart. II. Further effects of bovine ventricle protein (BVP) and antiarrhythmic peptide (AAP) on myocardial cells in culture. Chem Pharm Bull (Tokyo) 1980; 28: 3340-6.
98. Aonuma S, Kohama Y, Makino T, Fujisawa Y. Studies of heart. XXI. Amino acid sequence of antiarrhythmic peptide (AAP) isolated from atria. J Pharmacobiodyn 1982; 5: 40-8.
99. Dhein S, Manicone N, Müller A, Gerwin R, Ziskoven U, Irankhahi A, et al. A new synthetic antiarrhythmic peptide reduces dispersion of epicardial activation recovery interval and diminishes alterations of epicardial activation patterns induced by regional ischaemia. A mapping study. Naunyn-Schmiedeberg's Arch Pharmacol 1994; 350:174-84.
100. Grover R, Dhein S. Spatial structure determination of antiarrhythmic peptide using nuclear magnetic resonance spectroscopy. Peptides 1998; 19: 1725-9.
101. Weng S, Lauven M, Schaefer T, Polontchouk L, Grover R, Dhein S. Pharmacological modification of gap junction coupling by an antiarrhythmic peptide via protein kinase C activation. FASEB J 2002; 16: 1114-6
102. Dhein S, Larsen BD, Petersen JS, Mohr FW. Effects of the new antiarrhythmic peptide ZP123 on epicardial activation and repolarisation pattern. Cell Commun Adhes 2003; 10: 371-8.
103. Berthoud VM, Beyer EC, Seul KH. Peptide inhibitors of intercellular communication. Am J Physiol 2000; 279: L619-22.
104. Evans WH, Boitano S. Connexin mimetic peptides: specific inhibitors of gap-junctional intercellular communication. Biochem Soc Trans 2001; 29: 606-12.
105. Dahl G, Werner R, Levine E, Rabadan-Diehl C. Mutational analysis of gap junction formation. Biophys J 1992; 62: 172-80.
106. Warner A, Clements DK, Parikh S, Evans WH, DeHaan RL. Specific motifs in the external loops of connexin proteins can determine gap junction formation between chick heart myocytes. J Physiol (Lond) 1995; 488: 721-8.
107. Chaytor AT, Evans WH, Griffith TM. Peptides homologous to extracellular loop motifs of connexin 43 reversibly abolish rhythmic contractile activity in rabbit arteries. J Physiol (Lond) 1997; 503: 99-110.
108. 2+ signaling through gap junctions in airway cells. Am J Physiol 2000; 279: L623-30.
109. Kwak BR, Jongsma HJ. Selective inhibition of gap junction channel activity by synthetic peptides. J Physiol (Lond) 1999; 516: 679-85.
110. de Mello WC. Atrial natriuretic factor reduces cell coupling in the failing heart, an effect mediated by cyclic GMP. J Cardiovasc Pharmacol 1998; 32: 75-9.
111. de Mello WC. Gap junctional communication in excitable tissues: the heart as a paradigma. Prog Biophys Mol Biol 1994; 61: 1-35.
112. de Mello WC. Is an intracellular renin-angiotensin system involved in control of cell communication in heart? J Cardiovasc Pharmacol 1994; 23: 640-6.
113. Cook JL, Zhang Z, Re RN. In vitro evidence for an intracellular site of angiotensin action. Circ Res 2001; 89: 1138-46.
114. Giaume C, Cordier J, Glowinski J. Endothelins Inhibit Junctional Permeability in Cultured Mouse Astrocytes. Eur J Neurosci 1992; 4: 877-81.
115. Blomstrand F, Giaume C, Hansson E, Ronnback L. Distinct pharmacological properties of ET-1 and ET-3 on astroglial gap junctions and Ca(2+) signaling. Am J Physiol 1999; 277: C616-27.
116. Polontchouk L, Ebelt B, Jackels M, Dhein S. Chronic effects of endothelin 1 and angiotensin II on gap junctions and intercellular communication in cardiac cells. FASEB J 2002; 16: 87-9.
117. Campos-de-Carvalho AC, Eiras LA, Waltzman M, Hertzberg EL, Spray DC. Properties of channels from rat liver gap junction membrane fractions incorporated into planar lipid bilayers. Braz J Med Biol Res 1992; 25: 81-92.
118. Warner AE, Guthrie SC, Gilula NB. Antibodies to gap-junctional protein selectively disrupt junctional communication in the early amphibian embryo. Nature 1984; 311: 127-31.
119. Hertzberg EL, Spray DC, Bennett MV. Reduction of gap junctional conductance by microinjection of antibodies against the 27-kDa liver gap junction polypeptide. Proc Natl Acad Sci USA 1985; 82: 2412-6.
120. Yancey SB, John SA, Lal R, Austin BJ, Revel JP. The 43-kD polypeptide of heart gap junctions: immunolocalisation, topology, and functional domains. J Cell Biol 1989; 108: 2241-54.
121. Lal R, Laird DW, Revel JP. Antibody perturbation analysis of gap-junction permeability in rat cardiac myocytes. Pflügers Arch 1993; 422: 449-57.
122. Becker DL, Evans WH, Green CR, Warner A. Functional analysis of amino acid sequences in connexin43 involved in intercellular communication through gap junctions. J Cell Sci 1995; 108: 1455-67.
123. Bastide B, Jarry-Guichard T, Briand JP, Délèze J, Gros D. Effect of antipeptide antibodies directed against three domains of connexin43 on the gap junctional permeability of cultured heart cells. J Membr Biol 1996; 150: 243-53.
124. Boitano S, Dirksen ER, Evans WH. Sequence-specific antibodies to connexins block intercellular calcium signaling through gap junctions. Cell Calcium 1998; 23: 1-9.
125. Meyer RA, Laird DW, Revel JP, Johnson RG. Inhibition of gap junction and adherens junction assembly by connexin and A-CAM antibodies. J Cell Biol 1992; 119: 179-89.
126. Hofer A, Dermietzel R. Visualisation and functional blocking of gap junction hemichannels (connexons) with antibodies against external loop domains in astrocytes. Glia 1998; 24: 141-54.
127. Cruciani V, Mikalsen SO. Connexins, gap junctional intercellular communication and kinases. Biol Cell 2002; 94: 433-43.
128. Hervé JC, Sarrouilhe D. Modulation of junctional communication by phosphorylation: protein phosphatases, the missing link in the chain. Biol Cell 2002: 423-32.
129. Lampe PD, Lau AF. The effects of connexin phosphorylation on gap junctional communication. Int J Biochem Cell Biol 2004; 36: 1171-86.
130. Hervé JC, Plaisance I, Loncarek J, Duthe F, Sarrouilhe D. Is the junctional uncoupling elicited in rat ventricular myocytes by some dephosphorylation treatments due to changes in the phosphorylation status of Cx43 ? Eur Biophys J 2004; 33:201-10.
131. Duthe F, Dupont E, Verrecchia F, Plaisance I, Severs NJ, Sarrouilhe D, et al. Dephosphorylation agents depress gap junctional communication between rat cardiac cells without modifying the Connexin43 phosphorylation degree. Gen Physiol Biophys 2000; 19: 441-9.
132. Warn-Cramer BJ, Lau AF. Regulation of gap junctions by tyrosine protein kinases. Biochim Biophys Acta 2004; 1662: 81-95.
133. Srinivas M, Hopperstad MG, Spray DC. Quinine blocks specific gap junction channel subtypes. Proc Natl Acad Sci USA 2001; 98: 10942-7.
134. Spray DC, Rozental R, Srinivas M. Prospects for rational development of pharmacological gap junction channel blockers. Curr Drug Targets 2002; 3: 455-64.
135. Combes RD. The use of structure-activity relationships and markers of cell toxicity to detect non-genotoxic carcinogens. Toxicol In vitro 2000; 14: 387-99.
136. Mesnil M, Krutovskikh V, Omori Y, Yamasaki H. Role of blocked gap junctional intercellular communication in non-genotoxic carcinogenesis. Toxicol Lett 1995; 82-83: 701-6.
137. Trosko JE, Yotti LP, Warren ST, Tsushimoto G, Chang C. Inhibition of cell-cell communication by tumour promoters. Carcinogenesis Compr Surv 1982; 7: 565-85.
138. Budunova IV, Williams GM. Cell culture assays for chemicals with tumour-promoting or tumour-inhibiting activity based on the modulation of intercellular communication. Cell Biol Toxicol 1994; 10: 71-116.
139. Neyton J, Trautmann A. Physiological modulation of gap junction permeability. J Exp Biol 1986; 124: 993-114.
140. Giaume C, Marin P, Cordier J, Glowinski J, Premont J. Adrenergic regulation of intercellular communications between cultured striatal astrocytes from the mouse. Proc Natl Acad Sci USA 1991; 88: 5577-81.
141. Moore LK, Burt JM. Gap junction function in vascular smooth muscle: influence of serotonin. Am J Physiol 1995; 269: H1481-9.
142. Rorig B, Sutor B. Serotonin regulates gap junction coupling in the developing rat somatosensory cortex. Eur J Neurosci 1996; 8: 1685-95.
143. Bevans CG, Harris AL. Direct high affinity modulation of connexin channel activity by cyclic nucleotides. J Biol Chem 1999; 274: 3720-5.
144. Hossain MZ, Wilkens LR, Mehta PP, Loewenstein W, Bertram JS. Enhancement of gap junctional communication by retinoids correlates with their ability to inhibit neoplastic transformation. Carcinogenesis 1989; 10: 1743-8.
145. Rogers M, Berestecky JM, Hossain MZ, Guo HM, Kadle R, Nicholson BJ, et al. Retinoid-enhanced gap junctional communication is achieved by increased levels of connexin 43 mRNA and protein. Mol Carcinog 1990; 3: 335-43
146. Rivedal E, Sanner T. Regulation of gap junctional communication in Syrian hamster embryo cells by retinoic acid and 12-O-tetradecanoylphorbol-13-acetate. Carcinogenesis 1992; 13: 199-203.
147. Zhang DQ, McMahon DG. Direct gating by retinoic acid of retinal electrical synapses. Proc Natl Acad Sci USA 2000; 97: 14754-9.
148. Verrecchia F, Hervé JC. Reversible blockade of gap junctional communication by 2,3-butanedione monoxime in rat cardiac myocytes. Am J Physiol 1997; 272: C875-85.
149. Williams K. Interactions of polyamines with ion channels. Biochem J 1997; 325: 289-97.
150. Musa H, Gough JD, Lees WJ, Veenstra RD. Ionic blockade of the rat connexin40 gap junction channel by large tetraalkylammonium ions. Biophys J 2001; 81: 3253-74.
151. Musa H, Veenstra RD. Voltage-dependent blockade of connexin40 gap junctions by spermine. Biophys J 2003; 84: 205-19.
152. Saimi Y, Kung C. Calmodulin as an ion channel subunit. Annu Rev Physiol 2002; 64: 289-311.
153. Lees-Miller JP, Caveney S. Drugs that block calmodulin activity inhibit cell-to-cell coupling in the epidermis of Tenebrio molitor. J Membr Biol 1982; 69: 233-45.
154. Blödow A, Ngezahayo A, Ernst A, Kolb HA. Calmodulin antagonists suppress gap junction coupling in isolated Hensen cells of the guinea pig cochlea. Pflügers Arch 2003; 446: 36-41
155. Peracchia C, Bernardini G, Peracchia LL. Is calmodulin involved in the regulation of gap junction permeability? Pflügers Arch 1983; 399: 152-4.
156. Ahmad S, Martin PE, Evans WH. Assembly of gap junction channels: mechanism, effects of calmodulin antagonists and identification of connexin oligomerisation determinants. Eur J Biochem 2001; 268: 4544-52.
157. Saffitz JE, Laing JG, Yamada KA. Connexin expression and turnover: implications for cardiac excitability. Circ Res 2000; 86: 723-8.
158. May A, Puoti A, Gaeggeler HP, Horisberger JD, Rossier BC. Early effect of aldosterone on the rate of synthesis of the epithelial sodium channel subunit in A6 renal cells. J Am Soc Nephrol 1997; 8: 1813-22.
159. + channel expressed in epithelial Madin-Darby canine kidney cells. J Biol Chem 2002; 277: 9772-9.
160. Jugloff DG, Khanna R, Schlichter LC, Jones OT. Internalisation of the Kv1.4 potassium channel is suppressed by clustering interactions with PSD-95. J Biol Chem 2000; 275: 1357-64.
161. Monjaraz E, Navarrete A, Lopez-Santiago LF, Vega AV, Arias-Montano JA, Cota G. L-type calcium channel activity regulates sodium channel levels in rat pituitary GH3 cells. J Physiol (Lond) 2000; 523: 45-55.
162. Joseph SK. Biosynthesis of the inositol trisphosphate receptor in WB rat liver epithelial cells. J Biol Chem 1994; 269: 5673-9.
163. Chen X, Ferrington DA, Bigelow DJ, Michaelis EK. Protein half-lives of two subunits of an NMDA receptor-like complex, the 71-kDa glutamate-binding and the 80-kDa CPP-binding protein. Biochem Biophys Res Commun 1997; 241: 132-5.
164. Lukacs GL, Chang XB, Bear C, Kartner N, Mohamed A, Riordan JR, et al. The delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells. J Biol Chem 1993; 268: 21592-8.
165. Waisberg M, Shainberg A. Characterisation of muscarinic cholinergic receptors in intact myocardial cells in vitro. Biochem Pharmacol 1992; 43: 2327-34.
166. Akaaboune M, Culican SM, Turney SG, Lichtman JW. Rapid and reversible effects of activity on acetylcholine receptor density at the neuromuscular junction in vivo. Science 1999; 286: 503-7.
167. Ruch RJ, Guan X, Sigler K. Inhibition of gap junctional intercellular communication and enhancement of growth in BALB/c 3T3 cells treated with connexin43 antisense oligonucleotides. Mol Carcinog 1995; 14: 269-74.
168. Minkoff R, Bales ES, Kerr CA, Struss WE. Antisense oligonucleotide blockade of connexin expression during embryonic bone formation: evidence of functional compensation within a multigene family. Dev Genet 1999; 24: 43-56.
169. Moore LK, Burt JM. Selective block of gap junction channel expression with connexin-specific antisense oligodeoxynucleotides. Am J Physiol 1994; 267: C1371-80.
170. Ren P, de Feijter AW, Paul DL, Ruch RJ. Enhancement of liver cell gap junction protein expression by glucocorticoids. Carcinogenesis 1994; 15: 1807-13.
171. Stock A, Sies H, Stahl W. Enhancement of gap junctional communication and connexin43 expression by thyroid hormones. Biochem Pharmacol 1998; 55: 475-9.
172. Civitelli R, Ziambaras K, Warlow PM, Lecanda F, Nelson T, Harley J, et al. Regulation of connexin43 expression and function by prostaglandin E2 (PGE2) and parathyroid hormone (PTH) in osteoblastic cells. J Cell Biochem 1998; 68: 8-21.
173. Hu J, Cotgreave IA. Differential regulation of gap junctions by proinflammatory mediators in vitro. J Clin Invest 1997; 99: 2312-6.
174. Fernandez-Cobo M, Gingalewski C, Drujan D, De Maio A. Downregulation of connexin 43 gene expression in rat heart during inflammation. The role of tumour necrosis factor. Cytokine 1999; 11: 216-24.
175. Jara PI, Boric MP, Saez JC. Leukocytes express connexin 43 after activation with lipopolysaccharide and appear to form gap junctions with endothelial cells after ischaemia-reperfusion. Proc Natl Acad Sci USA 1995; 92: 7011-5.
176. Chandross KJ, Spray DC, Cohen RI, Kumar NM, Kremer M, Dermietzel R, et al. TNF alpha inhibits Schwann cell proliferation, connexin46 expression, and gap junctional communication. Mol Cell Neurosci 1996; 7: 479-500.
177. van Rijen HV, van Kempen MJ, Postma S, Jongsma HJ. Tumour necrosis factor alpha alters the expression of connexin43, connexin40, and connexin37 in human umbilical vein endothelial cells. Cytokine 1998; 10: 258-64.
178. Chanson M, Berclaz PY, Scerri I, Dudez T, Wernke-Dollries K,
179. Larson DM, Wrobleski MJ, Sagar GD, Westphale EM, Beyer EC. Differential regulation of connexin43 and connexin37 in endothelial cells by cell density, growth, and TGF-beta1. Am J Physiol 1997; 272: C405-15.
180. Pepper MS, Meda P. Basic fibroblast growth factor increases junctional communication and connexin 43 expression in microvascular endothelial cells. J Cell Physiol 1992; 153: 196-205.
181. Doble BW, Kardami E. Basic fibroblast growth factor stimulates connexin-43 expression and intercellular communication of cardiac fibroblasts. Mol Cell Biochem 1995; 143: 81-7.
182. Mensink A, Brouwer A, Van den Burg EH, Geurts S, Jongen WM, Lakemond CM, et al. Modulation of intercellular communication between smooth muscle cells by growth factors and cytokines. Eur J Pharmacol 1996; 310: 73-81.
183. Nadarajah B, Makarenkova H, Becker DL, Evans WH, Parnavelas JG. Basic FGF increases communication between cells of the developing neocortex. J Neurosci 1998; 18: 7881-90.
184. Abdullah KM, Luthra G, Bilski JJ, Abdullah SA, Reynolds LP, Redmer DA, et al. Cell-to-cell communication and expression of gap junctional proteins in human diabetic and nondiabetic skin fibroblasts: effects of basic fibroblast growth factor. Endocrine 1999; 10: 35-41.
185. Temme A, Traub O, Willecke K. Downregulation of connexin32 protein and gap-junctional intercellular communication by cytokine-mediated acute-phase response in immortalised mouse hepatocytes. Cell Tissue Res 1998; 294: 345-50.
186. Hu VW, Xie HQ. Interleukin-1 alpha suppresses gap junction-mediated intercellular communication in human endothelial cells. Exp Cell Res 1994; 213: 218-23.
187. John GR, Scemes E, Suadicani SO, Liu JS, Charles PC, Lee SC, et al. IL-1beta differentially regulates calcium wave propagation between primary human fetal astrocytes via pathways involving P2 receptors and gap junction channels. Proc Natl Acad Sci USA 1999; 96: 11613-8.
188. Duffy HS, John GR, Lee SC, Brosnan CF, Spray DC. Reciprocal regulation of the junctional proteins claudin-1 and connexin43 by interleukin-1beta in primary human fetal astrocytes. J Neurosci 2000; 20: RC114:1-6
189. Rozental R, Morales M, Mehler MF, Urban M, Kremer M, Dermietzel R, et al. Changes in the properties of gap junctions during neuronal differentiation of hippocampal progenitor cells. J Neurosci 1998; 18: 1753-62.
190. Moyer KE, Saggers GC, Allison GM, Mackay DR, Ehrlich HP. Effects of interleukin-8 on granulation tissue maturation. J Cell Physiol 2002; 193: 173-9.
191. Saffitz JE, Schuessler RB, Yamada KA. Mechanisms of remodeling of gap junction distributions and the development of anatomic substrates of arrhythmias. Cardiovasc Res 1999; 42: 309-17.
192. Jongsma HJ, Wilders R. Gap junctions in cardiovascular disease. Circ Res 2000; 86: 1193-7.
193. Spach MS, Heidlage JF, Dolber PC, Barr RC. Electrophysiological effects of remodeling cardiac gap junctions and cell size: experimental and model studies of normal cardiac growth. Circ Res 2000; 86: 302-11.
194. Severs NJ, Dupont E, Coppen SR, Halliday D, Inett E, Baylis D, et al. Remodelling of gap junctions and connexin expression in heart disease. Biochim Biophys Acta 2004; 1662: 138-48.
195. Goodenough DA, Paul DL. Beyond the gap: functions of unpaired connexon channels. Nat Rev Mol Cell Biol 2003; 4: 285-94.
196. Bennett MV, Contreras JE, Bukauskas FF, Saez JC. New roles for astrocytes: gap junction hemichannels have something to communicate. Trends Neurosci 2003; 26: 610-7.
197. John SA, Wang S-Y, Kondo R, Goldhaber JI, Weiss JN. Connexin-43 hemichannels opened by metabolic inhibition. J Biol Chem 1999; 274: 236-40.
198. Contreras JE, Sanchez HA, Eugenin EA, Speidel D, Theis M, Willecke K, et al. Metabolic inhibition induces opening of unapposed connexin 43 gap junction hemichannels and reduces gap junctional communication in cortical astrocytes in culture. Proc Natl Acad Sci USA 2002; 99: 495-500.
199. Bevans CG, Kordel M, Rhee SK, Harris AL. Isoform composition of connexin channels determines selectivity among second messengers and uncharged molecules. J Biol Chem 1998; 273: 2808-16.
200. Bevans CG, Harris AL. Regulation of connexin channels by pH. Direct action of the protonated form of taurine and other aminosulfonates. J Biol Chem 1999; 274: 3711-9.
201. Locke D, Koreen IV, Liu JY, Harris AL. Reversible pore block of connexin channels by cyclodextrins. J Biol Chem 2004; 279: 22883-92.
202. Ebihara L, Liu X, Pal JD. Effect of external magnesium and calcium on human connexin46 hemichannels. Biophys J 2003; 84: 277-86.
203. Chappell RL, Zakevicius J, Ripps H. Zinc modulation of hemichannel currents in Xenopus oocytes. Biol Bull 2003; 205: 209-11.
204. Malchow RP, Qian H, Ripps H. A novel action of quinine and quinidine on the membrane conductance of neurons from the vertebrate retina. J Gen Physiol 1994; 104: 1039-55.
205. Dixon DB, Takahashi K, Bieda M, Copenhagen DR. Quinine, intracellular pH and modulation of hemi-gap junctions in catfish horizontal cells. Vision Res 1996; 36: 3925-31.
206. Ripps H, Qian H, Zakevicius J. Pharmacological enhancement of hemi-gap-junctional currents in Xenopus oocytes. J Neurosci Methods 2002; 121: 81-92.
207. Plotkin LI, Manolagas SC, Bellido T. Transduction of cell survival signals by connexin-43 hemichannels. J Biol Chem 2002; 277: 8648-57.
208. Kondo RP, Wang SY, John SA, Weiss JN, Goldhaber JI. Metabolic inhibition activates a non-selective current through connexin hemichannels in isolated ventricular myocytes. J Mol Cell Cardiol 2000; 32: 1859-72.
209. Stout CE, Costantin JL, Naus CC, Charles AC. Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels. J Biol Chem 2002; 277: 10482-8.
210. Lopatin AN, Nichols CG. 2,3-Butanedione monoxime (BDM) inhibition of delayed rectifier DRK1 (Kv2.1) potassium channels expressed in Xenopus oocytes. J Pharmacol Exp Ther 1993; 265: 1011-6.
211. Weiler R, Pottek M, He S, Vaney DI. Modulation of coupling between retinal horizontal cells by retinoic acid and endogenous dopamine. Brain Res Rev 2000; 32: 121-9.
212. Cohen-Salmon M, Ott T, Michel V, Hardelin JP, Perfettini I, Eybalin M, et al. Targeted ablation of connexin26 in the inner ear epithelial gap junction network causes hearing impairment and cell death. Curr Biol 2002; 12: 1106-11.
213. Brink PR. Are gap junction channels a therapeutic target and if so what properties are best exploited? Curr Drug Targets 2002; 3: 417-25.
214. Huang X, Liu H, Cui M, Fu W, Yu K, Chen K, et al. Simulating the interactions of toxins with K+ channels. Curr Pharm Design 2004; 10(9): 1057-67.
215. McMahon EG. Eplerenone, a new selective aldosterone blocker. Curr Pharm Design 2003; 9(13): 1065-75.
216. Varro A, Nanasi PP, Acsai K, Virag L, Papp JG. Cardiac sarcolemmal ion channels and transporters as possible targets for antiarrhythmic and positive inotropic drugs: strategies of the past-perspectives of the future. Curr Pharm Design 2004; 10(20): 2411-27.